Publication
Abstract
Realization of part of clinical trial called: Euclid: A randomized, double-blind, parallel group, multicenter phase IIIb study to compare ticagrelor with c1opidogrel treatment on the risk of cardiovascular death, myocardial infarction and ischemic stroke in patients with established Peripheral Artery Disease